Visceral and Not Subcutaneous Abdominal Adiposity Reduction Drives the Benefits of a 1‐Year Lifestyle Modification Program

Excess visceral adipose tissue (VAT) is associated with an increased cardiometabolic risk. The study examined whether changes in cardiometabolic risk markers after a 1‐year lifestyle intervention in viscerally obese men were associated with changes in VAT or with changes in subcutaneous abdominal ad...

Full description

Saved in:
Bibliographic Details
Published in:Obesity (Silver Spring, Md.) Md.), 2012-06, Vol.20 (6), p.1223-1233
Main Authors: Borel, Anne‐Laure, Nazare, Julie‐Anne, Smith, Jessica, Alméras, Natalie, Tremblay, Angelo, Bergeron, Jean, Poirier, Paul, Després, Jean‐Pierre
Format: Article
Language:English
Subjects:
Abdomen
Absorptiometry, Photon
Adult
Aged
Biomarkers - blood
Body Composition
Cardiovascular system
Cholesterol, HDL - blood
Diet
Dyslipidemias - blood
Dyslipidemias - physiopathology
Exercise
Feeding Behavior
Glucose Tolerance Test
Humans
Intra-Abdominal Fat - diagnostic imaging
Intra-Abdominal Fat - metabolism
Male
Men
Metabolism
Middle Aged
Obesity
Obesity - blood
Obesity - complications
Obesity - diagnostic imaging
Risk factors
Risk Reduction Behavior
Subcutaneous Fat, Abdominal - diagnostic imaging
Treatment Outcome
Triglycerides - blood
Waist Circumference
Weight Loss
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Excess visceral adipose tissue (VAT) is associated with an increased cardiometabolic risk. The study examined whether changes in cardiometabolic risk markers after a 1‐year lifestyle intervention in viscerally obese men were associated with changes in VAT or with changes in subcutaneous abdominal adipose tissue (SAT). The relative contributions of changes in global adiposity vs. changes in cardiorespiratory fitness to changes in VAT were also quantified. One hundred and forty four men were selected on the basis of an increased waist circumference (≥90 cm) associated with dyslipidemia (triglycerides ≥1.69 and/or high‐density lipoprotein (HDL)‐cholesterol
ISSN:1930-7381
1930-739X
DOI:10.1038/oby.2011.396